Literature DB >> 17132744

Testosterone and cognitive function: current clinical evidence of a relationship.

Olivier Beauchet1.   

Abstract

BACKGROUND: Testosterone levels decline as men age, as does cognitive function. Whether there is more than a temporal relationship between testosterone and cognitive function is unclear. Chemical castration studies in men with prostate cancer suggest that low serum testosterone may be associated with cognitive dysfunction. Low testosterone levels have also been observed in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). This paper reviews the current clinical evidence of the relationship between serum testosterone levels and cognitive function in older men.
METHODS: A systematic literature search was conducted using PubMed and EMBASE to identify clinical studies and relevant reviews that evaluated cognitive function and endogenous testosterone levels or the effects of testosterone substitution in older men.
RESULTS: Low levels of endogenous testosterone in healthy older men may be associated with poor performance on at least some cognitive tests. The results of randomized, placebo-controlled studies have been mixed, but generally indicate that testosterone substitution may have moderate positive effects on selective cognitive domains (e.g. spatial ability) in older men with and without hypogonadism. Similar results have been found in studies in patients with existing AD or MCI.
CONCLUSIONS: Low endogenous levels of testosterone may be related to reduced cognitive ability, and testosterone substitution may improve some aspects of cognitive ability. Measurement of serum testosterone should be considered in older men with cognitive dysfunction. For men with both cognitive impairment and low testosterone, testosterone substitution may be considered. Large, long-term studies evaluating the effects of testosterone substitution on cognitive function in older men are warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132744     DOI: 10.1530/eje.1.02306

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  45 in total

Review 1.  Mild cognitive impairment and dementia: the importance of modifiable risk factors.

Authors:  Thorleif Etgen; Dirk Sander; Horst Bickel; Hans Förstl
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

3.  Passing through the wall: on outings, exodus, angels, and the ark.

Authors:  Richard Joel Wassersug
Journal:  J Relig Health       Date:  2008-12-30

Review 4.  [Neuro-enhancement. Brain doping].

Authors:  H Förstl
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

Review 5.  What are critical outcome measures for patients receiving pituitary replacement following brain injury?

Authors:  Sorin G Beca; Walter M High; Brent E Masel; Kurt A Mossberg; Randall J Urban
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 6.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

7.  Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.

Authors:  Fang Yang; Keming Wang; Xiangdong Du; Huiqiong Deng; Hanjing Emily Wu; Guangzhong Yin; Yuping Ning; Xingbing Huang; Antonio L Teixeira; João de Quevedo; Jair C Soares; Xiaosi Li; XiaoE Lang; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2018-11-19       Impact factor: 4.530

8.  Estrogen, testosterone, and sequential movement in men.

Authors:  Jessica A Siegel; Laura A Young; Michelle B Neiss; Mary H Samuels; Charles E Roselli; Jeri S Janowsky
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

9.  Cognition is not modified by large but temporary changes in sex hormones in men.

Authors:  Laura A Young; Michelle B Neiss; Mary H Samuels; Charles E Roselli; Jeri S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2009-10-30       Impact factor: 5.958

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.